Schedule 13G ownership disclosure

Madrigal Pharmaceuticals Inc

Security class unavailable · CUSIP: 558868105

Event date: 2022-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
1.2100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001172661-23-001131
Form type
SC 13G/A
Filer
ARMISTICE CAPITAL, LLC
CIK
CIK 1601086
Filed
Feb 14, 2023
Reporting period
Dec 31, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub